Something Fishy is Going On
Published April 9 2019
Aquaculture is about biological risk. How may life scientist help better control this risk
ShareLab kicked off 2019 with an excursion to Bremnes Seashore’s fantastic hatchery at Trovåg and has since then spent time with the industry at every major aquaculture conference. We already have aquaculture startups within biofilm, lice vaccines, salmon genomics, and submersible pens. Going forward we would like to see DNA vaccines, pathogen bioinformatics, biological counter lice measures, and rapid diagnostic tests.
Bioprocessing: Stirred, But Not Shaken
Published Descember 29th 2019
Do you want to give your shake flasks cultivation an extra boost? Then do not wait any longer and transfer to a bioreactor or fermenter. ShareLab will teach you how. Sign up for the workshop 6 February 2019.
The workshop is a collaboration between Eppendorf, SINTEF, and ShareLab. The workshop will kick off with a teach-in on the advantages and challenges of shaker cultures, before participants are introduced to bioreactors by Eppendorf experts. Bioreactors are not just about scaling up and scaling down, but also to gain control and enhance reproducibility. You probably know that bacteria, yeast, plant cells, insect cells and mammalian cells are cultured in bioreactors, but did you know that stems cells may also be cultured this way? Inga Marie Aasen from SINTEF will share great cases and work from her labs and after lunch there will be a hands-on demonstration of a bioreactor in ShareLabs. We will use the the Eppendorf BioFlo® 120 and the DASbox® as demonstration systems.
Challenges with you own culturing, fermentation or expression? No problem, bring your questions and consult the experts during the workshop.
Check out the program and sign up HERE.
Corticalis: Creating optimal bone regenerationPublished Descember 10th 2018
Corticalis AS was founded in 2001 by Profs Jan Eirik Ellingsen and Staale Petter Lyngstadaas to make material contributions to dentistry. Still, the company’s main assets are immaterial. Since 2001 Corticalis has successfully developed, out-licensed, and sold a number of patent portfolios to major players in the dental implant industry.
"Our vision at Corticalis is that all our products should be thoroughly tested - to more stringent standards than those found in current regulations. We use known materials and manufacture our products in a new way. This is why we believe our products will be a game changer in the medical device market."
Håvard J. Haugen (Research manager)
Corticalis’ main goal is to create optimal bone regeneration. In order to do this, they develop products that enable bone regeneration from both a biological and a 3D structural, mechanical guided (3D-GBR) bone regeneration approach. Corticalis focuses R & D on three new technologies: a titanium based ceramic bone graft material (NuBone®), a synthetic peptide family (NuPep™), and a paste for peri-implantitis treatment (NuGel™). NuGel™ has also been developed to combat oral bacterial infections without antibiotics, to aid in the struggle against MDR bacteria.
"Conditions such as trauma, tumors, cancer, periodontitis and osteoporosis may lead to bone loss, reduced bone growth and lower bone volume. To help these patients, it is critical to find methods to improve bone growth and to regain bone anatomy. Our NuBone may be used as a framework for the cells participating in the bone regeneration process, but also as a substitute for lost bone structure."
S. Petter Lyngstadaas (CEO)
As entrepreneurs, it is important for Corticalis to be part of a community with other like-minded colleagues. ShareLab offers this possibility. In addition, the company also has access to the lab-space needed to continue experimenting and enhancing their products - ShareLab fits the bill perfectly!
The ShareLab team is excited to have Corticalis as a member and wish them the best of luck!
Published by: Iselin H. Wood
KARINA KOVALCHUK WINS LABORATION'18
Published November 24th 2018
The Aker BioMarine and ShareLab Laboration challenge winner is Karina Kovalchuck - congratulations! Karina won a full year at ShareLab (sponsored by Aker BioMarine) with access to lab, co-working space, and mentoring. B'ZEOS, the runner-up, took home 3 full months at ShareLab.
The Laboration challenge started out with eight competitors pitching their ideas to the Aker BioMarine panel on October 11th. The final "pitch-off" between Karina Kovalchuk's vitamin C project and B'ZEOS' bioplastic was held on November 22nd.
For an introduction to the Laboration winner Karina Kovalchuck, check out this video:
Video: Aker BioMarine
Published by: Iselin H. Wood
LABORATION: Panel Day
Published October 11th 2018
The first ever Laboration contestants made their pitches to Aker BioMarine panel on October 11. The specially selected eight candidates are competing for a free 12 month membership at ShareLab, with access to lab & lab management, office space, and mentorships – generously sponsored by Aker BioMarine.
The participants’ ideas will be evaluated on innovation level, commercial potential, societal benefits, and several other key factors.
Armend G. Håti, Ph.D. and director of Product Development at Aker BioMarine, said:
"At Aker BioMarine we are strong supporters of thinking outside the ordinary and we always seek to support innovators that also share our drive to improve human and planetary health. Our sponsorship with ShareLab is one example of this. We are pleased to have received lots of interesting biotech cases and were impressed by the cases in our pitch-competition today."
What happens now?
The panel will make their picks, and in November, the three top picks face off in the Laboration final. Who will make out with the head prize? Follow us for updates!
Who is in the running?
Meet our Laboration contestans on our Facebook page.
"Our innovators are the heart of ShareLab. The Laboration sponsorship from Aker BioMarine is both a great opportunity for us to include new members to the ShareLab family and a path for entrepreneurs to lift their projects to a completely new level. We very much look forward to welcoming the Laboration winner"
Esben A. Nilssen, Managing Partner of ShareLab
Published by: Iselin H. Wood
Sample preparation and real-time PCR
VWR hosted a sold-out lab course when they invited to training in “sample preparation and real-time PCR” in ShareLab on September 17th.
It was obvious that ShareLab would be the perfect place to facilitate a lab course with mix of theory and hands-on training including analysis. ShareLab Lab Manager and VWR employee, Inderjit S. Marjara, hosted the full-day course with help from VWR team. Inderjit has over 20 years of experience within biotechnology and lab work. He was enthusiastic after the event:
“Although it takes a lot of effort to host such training, it was all worth it. The best part was the enthusiastic participants, they showed curiosity and asked good questions throughout the event. I soon realized that such training should be offered more often, not only on qPCR and sample handling but also other topics.”
- Inderjit S. Marjara, ShareLab and VWR
Lab course consisted of the whole workflow from taking the sample, through long-term storage, extraction of DNA and qPCR. Followed by a brief section on qPCR analysis. It is more or less an impossible task to cover all this in detail, but active participants and good discussions is key and shows what should be emphasized on.
Last month’s event was fully booked w/waiting list established. New lab courses are scheduled and will be published later this fall and after Christmas, follow ShareLab newsletter and Facebook page to stay updated.
Single-use plastic straws are top 10 debris in the oceans. About 180 billion of plastic drinking straws are consumed each year in the world, according to a report of Seas at Risk. Drinking straws are currently used as a symbol for the fight against plastic and many organisations claim their prohibition.
New ShareLab member B'ZEOS may have a solution to the problem with their Zero-waste, Edible, nature’s Origin and Sugar-free drinking straw (ZEOS straw), an alternative to plastic drinking straws.
“Fighting climate change and plastic littering is our ambition and adding seaweed into the equation is our mission! With ZEOS straws we do more than cutting CO2 emissions, we encourage new generations to be the change they want to see in this world (Gandhi). Our slogan is simple: Eat it, Bite it or Let it. But at the end, YOU make it disappear. Thanks Sharelab for having us on-board!”
– Guy Maurice, Founder B’ZEOS
What is ZEOS straw? It is edible and compostable in normal condition in contrast to PLA, starch and other so-called biodegradable plastics on the market. It’s mainly produced from certified seaweed. In contrast to the use of fossil resources, marine resources are inexhaustible, quickly renewable, bio-compostable, fertilizing, energy-efficient and seaweed have negative CO2 emission.
“We’re happy having Guy and Caroline with us and look forward to helping B’ZEOS to develop an alternative to plastic drinking straws. I have already tried the first iteration of their edible innovation and needless to say, they will weed out all competition. Plastics shall clutch at straws!”
– Esben Nilssen, Managing Partner ShareLab
CEO Matts Johansen of Aker BioMarine ASA (Photo: Aker BioMarine)
Innovators Wanted – Own office not required
ShareLab and Aker BioMarine are launching a competition to find the next generation of life science and marine innovators.
Published July 3rd 2018
We are looking for teams or start-ups with unique ideas or concepts. Aspiring innovators will be selected based on a single page executive summary of their idea or concept.
At stake is a one-year membership to ShareLab, a new co-working laboratory and office space, tailor-made for life science start-ups, located in Oslo, Norway.
The winning team will be awarded an Aker BioMarine-funded spot in the lab and office facilities, as well as benefit from active mentorship and access to Aker Biomarine’s network. Neither Aker BioMarine nor ShareLab will retain any ownership or stake in the winning idea.
Our knowledge and utilization of the ocean is still so limited
Matts Johansen, CEO of Aker BioMarine, explains why collaborative projects and creative environments like ShareLab are so important for an innovation-driven industry such as his:
“The way we see it, this is about increasing the value creation from the ocean’s resources. To cope with the challenges of the future it would be arrogant not to believe that some of the solutions may lay within the oceans. Especially as our knowledge and utilization of the ocean is still so limited.”
Adding, “ShareLab represents a unique opportunity to foster the development of such solutions. They are on the same mission, to find sustainable and innovative new products. At the end of the day it is about breaking down barriers and removing friction to enable the growth and development of good ideas.”
Life science will be a vital part of Norwegian industry
Esben A. Nilssen, Managing Partner at ShareLab, says, “We are thrilled to see Aker BioMarine sign on as ShareLab partner only months after our official opening by prime minister Erna Solberg. This is testimony to our belief that life science will be a vital part of Norwegian industry in the future. Sustainable development of our oceans and forests, growth of our seafood industry, as well as human and animal health all depend on life science innovation. Aker BioMarine is one of Europe’s most innovative companies – of course they join the ShareLab community!”
Recently winning that title in the prestigious European Business Awards, Aker BioMarine’s continued success, and indeed the very market it helped create, is built upon finding new and ground-breaking ways to work.
Johansen says, “Innovative people and new ideas are the very foundation of our success. We are constantly on the lookout for explorers who think outside the ordinary, while keeping their feet firmly on the ground.”
The deadline for entries to the competition is September 15thand the winner will be announced on October 3rd.
Dr Stenar Thoresen, Medical Director at Abbvie (Photo: Anne Grete Storvik)
ShareLab - important for the success of building a strong Norwegian healthcare industry
Published June 13th 2018
Abbvie has partnered with ShareLab to build the health industry in Norway. In this article (link below), Medical Director Steinar Thoresen (Abbvie) and Managing Partner Esben A. Nilssen explain why ShareLab will make a difference, and why the Norwegian government's health industry announcement is important.
Should we succeed in building strong health education, we depend on good information exchange and close cooperation!
Read the full article here (The article is written in Norwegian)
Published by: Iselin H. Wood